Heart, Lung and Circulation
Volume 18, Issue 2 , Pages 123-130 , April 2009

Quantitative and Temporal Differences in Coagulation, Fibrinolysis and Platelet Activation after On-Pump and Off-Pump Coronary Artery Bypass Surgery

  • Michael P. Vallely, PhD, FRACS

      Affiliations

    • The Baird Institute, 304/100 Carillon Avenue, Newtown, Sydney, NSW 2042, Australia
    • Cardiothoracic Surgical Unit, Royal Prince Alfred Hospital, Sydney, Australia
    • Corresponding Author InformationCorresponding author. Tel.: +61 295501933.
  • ,
  • Paul G. Bannon, PhD, FRACS

      Affiliations

    • The Baird Institute, 304/100 Carillon Avenue, Newtown, Sydney, NSW 2042, Australia
    • Cardiothoracic Surgical Unit, Royal Prince Alfred Hospital, Sydney, Australia
    • Faculty of Medicine, The University of Sydney, Sydney, Australia
  • ,
  • Matthew S. Bayfield, FRACS

      Affiliations

    • The Baird Institute, 304/100 Carillon Avenue, Newtown, Sydney, NSW 2042, Australia
    • Cardiothoracic Surgical Unit, Royal Prince Alfred Hospital, Sydney, Australia
  • ,
  • Clifford F. Hughes, AO, FRACS

      Affiliations

    • The Baird Institute, 304/100 Carillon Avenue, Newtown, Sydney, NSW 2042, Australia
    • Cardiothoracic Surgical Unit, Royal Prince Alfred Hospital, Sydney, Australia
    • Faculty of Medicine, The University of Sydney, Sydney, Australia
  • ,
  • Len Kritharides, PhD, FRACP

      Affiliations

    • The Baird Institute, 304/100 Carillon Avenue, Newtown, Sydney, NSW 2042, Australia
    • Faculty of Medicine, The University of Sydney, Sydney, Australia
    • Department of Cardiology, Concord Repatriation and General Hospital, Sydney, Australia

Received 14 March 2008 ,Revised 22 June 2008 ,Accepted 28 August 2008.

References 

  1. Parolari A, Mussoni L, Frigerio M, Naliato M, Alamanni F, Galanti A, et al. Increased prothrombotic state lasting as long as one month after on-pump and off-pump coronary surgery. J Thorac Cardiovasc Surg. 2005;130(2):303–308
  2. Casati V, Guerra F, D’Angelo A. About the activation of the coagulation system during on-pump and off-pump coronary surgery and the use of antifibrinolytic drugs. J Thorac Cardiovasc Surg. 2006;132(3):733–734(author reply 734)
  3. Biglioli P, Cannata A, Alamanni F, Naliato M, Porqueddu M, Zanobini M, et al. Biological effects of off-pump vs. on-pump coronary artery surgery: focus on inflammation, hemostasis and oxidative stress. Eur J Cardiothorac Surg. 2003;24(2):260–269
  4. Wahba A, Rothe G, Lodes H, Barlage S, Schmitz G. The influence of the duration of cardiopulmonary bypass on coagulation, fibrinolysis and platelet function. Thorac Cardiovasc Surg. 2001;49(3):153–156
  5. Mariani MA, Gu YJ, Boonstra PW, Grandjean JG, van Oeveren W, Ebels T. Procoagulant activity after off-pump coronary operation: is the current anticoagulation adequate?. Ann Thorac Surg. 1999;67(5):1370–1375
  6. Casati V, Gerli C, Franco A, Della Valle P, Benussi S, Alfieri O, et al. Activation of coagulation and fibrinolysis during coronary surgery: on-pump versus off-pump techniques. Anesthesiology. 2001;95(5):1103–1109
  7. Vallely MP, Bannon PG, Kritharides L. The systemic inflammatory response syndrome and off-pump cardiac surgery. Heart Surg Forum. 2001;4(Suppl 1):S7–S13
  8. Cardigan RA, Hamilton-Davies C, McDonald S, Purdy G, Mackie IJ, Webb AR, et al. Haemostatic changes in the pulmonary blood during cardiopulmonary bypass. Blood Coagul Fibrinol. 1996;7(5):567–577
  9. Chung JH, Gikakis N, Rao AK, Drake TA, Colman RW, Edmunds LH. Pericardial blood activates the extrinsic coagulation pathway during clinical cardiopulmonary bypass. Circulation. 1996;93(11):2014–2018
  10. Knudsen L, Hasenkam JM, Kure HH, Hughes P, Bellaiche L, Ahlburg P, et al. Monitoring thrombin generation with prothrombin fragment 1, 2 assay during cardiopulmonary bypass surgery. Thromb Res. 1996;84(1):45–54
  11. Tsang GM, Allen S, Pagano D, Wong C, Graham TR, Bonser RS. von Willebrand factor and urinary albumin excretion are possible indicators of endothelial dysfunction in cardiopulmonary bypass. Eur J Cardiothorac Surg. 1998;13(4):385–391
  12. Burman JF, Chung HI, Lane DA, Philippou H, Adami A, Lincoln JC. Role of factor XII in thrombin generation and fibrinolysis during cardiopulmonary bypass. Lancet. 1994;344(8931):1192–1193
  13. Boisclair MD, Lane DA, Philippou H, Esnouf MP, Sheikh S, Hunt B, et al. Mechanisms of thrombin generation during surgery and cardiopulmonary bypass. Blood. 1993;82(11):3350–3357
  14. Koster A, Fischer T, Praus M, Haberzettl H, Kuebler WM, Hetzer R, et al. Hemostatic activation and inflammatory response during cardiopulmonary bypass: impact of heparin management. Anesthesiology. 2002;97(4):837–841
  15. Philippou H, Adami A, Davidson SJ, Pepper JR, Burman JF, Lane DA. Tissue factor is rapidly elevated in plasma collected from the pericardial cavity during cardiopulmonary bypass. Thromb Haemost. 2000;84(1):124–128
  16. Ernofsson M, Thelin S, Siegbahn A. Monocyte tissue factor expression, cell activation, and thrombin formation during cardiopulmonary bypass: a clinical study. J Thorac Cardiovasc Surg. 1997;113(3):576–584
  17. Valen G, Blomback M, Sellei P, Lindblom D, Vaage J. Release of von Willebrand factor by cardiopulmonary bypass, but not by cardioplegia in open heart surgery. Thromb Res. 1994;73(1):21–29
  18. Perrin EJ, Ray MJ, Hawson GA. The role of von Willebrand factor in haemostasis and blood loss during and after cardiopulmonary bypass surgery. Blood Coagul Fibrinol. 1995;6(7):650–658
  19. Tabuchi N, de Haan J, Boonstra PW, van Oeveren W. Activation of fibrinolysis in the pericardial cavity during cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1993;106(5):828–833
  20. Nguyen NT, Owings JT, Gosselin R, Pevec WC, Lee SJ, Goldman C, et al. Systemic coagulation and fibrinolysis after laparoscopic and open gastric bypass. Arch Surg. 2001;136(8):909–916
  21. Hunt BJ, Parratt RN, Segal HC, Sheikh S, Kallis P, Yacoub M. Activation of coagulation and fibrinolysis during cardiothoracic operations. Ann Thorac Surg. 1998;65(3):712–718
  22. Rifon J, Paramo JA, Prosper F, Collados MT, Sarra J, Rocha E. Thrombin-antithrombin complexes and prothrombin fragment 1+2 in aorto-coronary bypass surgery: relation to graft occlusion. Hematol Pathol. 1994;8(1-2):35–42
  23. Zajtchuk R, Collins GJ, Holley PW, Heydron WH, Schuchmann GF, Hamaker WR. Coagulation factors influencing thrombosis of aorta-coronary bypass grafts. J Thorac Cardiovasc Surg. 1977;73(2):309–311
  24. Woo YJ, Atluri P, Grand TJ, Hsu V, Gardner TJ. Should standard on-pump protamine dosing formulas be recalculated for off-pump coronary artery bypass grafting?. Heart Surg Forum. 2004;7(1):42–44
  25. Tanaka KA, Thourani VH, Williams WH, Duke PG, Levy JH, Guyton RA, et al. Heparin anticoagulation in patients undergoing off-pump and on-pump coronary bypass surgery. J Anesth. 2007;21(3):297–303
  26. Hangler HB, Pfaller K, Ruttmann E, Hoefer D, Schachner T, Laufer G, et al. Effects of intracoronary shunts on coronary endothelial coating in the human beating heart. Ann Thorac Surg. 2004;77(3):776–780
  27. Rifon J, Paramo JA, Panizo C, Montes R, Rocha E. The increase of plasminogen activator inhibitor activity is associated with graft occlusion in patients undergoing aorto-coronary bypass surgery. Br J Haematol. 1997;99(2):262–267
  28. Moor E, Blomback M, Silveira A, Wiman B, Cederlund K, Bergstrand L, et al. Haemostatic function in patients undergoing coronary artery bypass grafting: peroperative perturbations and relations to saphenous vein graft closure. Thromb Res. 2000;98(1):39–49
  29. Ray MJ, Marsh NA, Hawson GA. Relationship of fibrinolysis and platelet function to bleeding after cardiopulmonary bypass. Blood Coagul Fibrinol. 1994;5(5):679–685
  30. Komai H, Haworth SG. Effect of cardiopulmonary bypass on the circulating level of soluble GMP-140. Ann Thorac Surg. 1994;58(2):478–482
  31. Wei M, Kuukasjarvi P, Laurikka J, Kaukinen S, Iisalo P, Laine S, et al. Soluble adhesion molecules and myocardial injury during coronary artery bypass grafting. World J Surg. 2003;27(2):140–144
  32. Parolari A, Mussoni L, Frigerio M, Naliato M, Alamanni F, Polvani GL, et al. The role of tissue factor and P-selectin in the procoagulant response that occurs in the first month after on-pump and off-pump coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2005;130(6):1561–1566
  33. Ballotta A, Saleh HZ, El Baghdady HW, Gomaa M, Belloli F, Kandil H, et al. Comparison of early platelet activation in patients undergoing on-pump versus off-pump coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2007;134(1):132–138
  34. Ley K. Molecular mechanisms of leukocyte recruitment in the inflammatory process. Cardiovasc Res. 1996;32(4):733–742
  35. Lotan D, Prince T, Dagan O, Keller N, Ben-Abraham R, Weinbroum A, et al. Soluble P-selectin and the postoperative course following cardiopulmonary bypass in children. Paediatr Anaesth. 2001;11(3):303–308
  36. Hayashi Y, Sawa Y, Nishimura M, Tojo SJ, Ichikawa H, Satoh H, et al. P-selectin monoclonal antibody may attenuate the whole body inflammatory response induced by cardiopulmonary bypass. Asaio J. 2000;46(3):334–337

PII: S1443-9506(08)00866-4

doi: 10.1016/j.hlc.2008.08.012

Heart, Lung and Circulation
Volume 18, Issue 2 , Pages 123-130 , April 2009